AnteoTechAnteoTechAnteoTechAnteoTech
  • Home
  • About
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
    • ADVISORY BOARDS
  • Life Science
    • ANTEOBIND
      • ANTEOBIND PUBLICATIONS
    • PRODUCTS
    • CONTRACT SERVICES
    • CASE STUDIES
    • WEBINARS
  • Energy
    • WEBINARS
  • EuGeni
  • Newsroom
  • Investors
    • 2021 ANNUAL GENERAL MEETING
    • ASX ANNOUNCEMENTS
    • CORPORATE GOVERNANCE & COMPANY POLICY
    • VIEW ON ASX
  • Customer Login
  • Contact

Spanish and Portuguese Distribution Agreement for EuGeni

    Home Uncategorized Spanish and Portuguese Distribution Agreement for EuGeni
    NextPrevious

    Spanish and Portuguese Distribution Agreement for EuGeni

    By AnteoTech | Uncategorized | 0 comment | 18 October, 2021 |

    AnteoTech broadens European market exposure, securing a Spanish and Portuguese Distribution Agreement for EuGeni

    AnteoTech is pleased to welcome another newly appointed distributor to the EuGeni family. Most recently, AnteoTech has appointed Vitro Master Diagnostica (Vitro) for Spain and Portugal, the sixth exclusive distributor in Europe.

    Following the appointment, Vitro Master Vitro S.A. and its Portuguese subsidiary, Master-InVitro will sell and distribute the EuGeni Reader platform and SARS-CoV-2 Antigen Rapid Diagnostic Test (RDT)  in Spain and Portugal and significantly strengthen AnteoTech’s footprint in Europe.

    Vitro S.A. is a Spanish private corporation specialising in the development, manufacture and distribution of in-vitro diagnostic (IVD) instruments, software and reagents. The group focuses on solutions which use non-invasive techniques such as immunohistochemistry and molecular biology diagnostics, making the EuGeni platform the perfect fit.

    Vitro boast more than 30 years’ of experience in the supply of IVD reagents and platforms to a large number of Spanish hospitals and reference laboratories. Master in-Vitro, the Portuguese subsidiary, has extensive expertise in importing and marketing diagnostic products and services in Portugal.

    AnteoTech will work together with Vitro S.A. and Master-InVitro to fulfil all necessary regulatory registration requirements. In parallel, AnteoTech will provide sales, marketing, and technical training to both parties to ensure a streamlined go-to-market execution.

    AnteoTech CEO Derek Thomson said, “I am excited to be signing a further distributor in Europe. This brings our global distributor count to nine covering 17 distribution territories. Vitro have a strong track record in the IVD space and are perfectly positioned to execute on our EuGeni Platform strategy, placing readers into clinics and laboratories across the two countries.  We have been working with Vitro over the past 6 months as they trialled the EuGeni platform with their customers in Spain, and we are very pleased for them and their subsidiary to be adding the EuGeni Platform to their IVD offering. We welcome Vitro to the team and look forward to building a strong relationship with them over the coming years.”

     

    No tags.

    AnteoTech

    More posts by AnteoTech

    Related Post

    • Exxe Appointed as Italian Distributor

      By AnteoTech | 0 comment

      AnteoTech welcomes EXXE S.r.l (EXXE) to the EuGeni family. Based in Milan, Italy, EXXE is AnteoTech’s fifth European distributor for the EuGeni Reader platform and SARS-CoV-2 Antigen Rapid Diagnostic Test (RDT). We are excited atRead more

    • AnteoTech renews AnteoBind contract with Ellume

      By AnteoTech | 0 comment

      AnteoTech is pleased to advise that it has renewed its contract with leading healthcare diagnostic partner Ellume Ltd. (“Ellume”) for the supply of AnteoBind to be used in Ellume’s range of tests. Ellume is anRead more

    • Australian-made RATs await TGA approval amid rapid antigen test shortage

      By AnteoTech | 0 comment

      Australian-made RATs await TGA approval amid rapid antigen test shortage  Read more

    NextPrevious

    Recent Posts

    • Australian-made RATs await TGA approval amid rapid antigen test shortage
    • AnteoTech renews AnteoBind contract with Ellume
    • Spanish and Portuguese Distribution Agreement for EuGeni
    • Exxe Appointed as Italian Distributor

    Recent Comments

      Quick Links

      • About
      • Life Science
      • Energy
      • Investors
      • Customer Login

      Investors

      • ASX Announcements
      • Corporate Governance & Company Policy
      • Financial Reporting
      • Share Price Information

      Contact Us

      If you have any general questions about our products or technology, contact customer support on (07) 3219 0085 or email contact@anteotech.com. For all technical support, please email support@anteotech.com.

      For all investor-related queries please email investors@anteotech.com.

      Copyright © AnteoTech 2021. All rights reserved. AnteoCoat/AnteoBind are trademarks of the AnteoTech group of companies. All other trademarks referenced are owned by their respective companies.
      Website by Start Digital
      • Home
      • About
        • MANAGEMENT TEAM
        • BOARD OF DIRECTORS
        • ADVISORY BOARDS
      • Life Science
        • ANTEOBIND
          • ANTEOBIND PUBLICATIONS
        • PRODUCTS
        • CONTRACT SERVICES
        • CASE STUDIES
        • WEBINARS
      • Energy
        • WEBINARS
      • EuGeni
      • Newsroom
      • Investors
        • 2021 ANNUAL GENERAL MEETING
        • ASX ANNOUNCEMENTS
        • CORPORATE GOVERNANCE & COMPANY POLICY
        • VIEW ON ASX
      • Customer Login
      • Contact
      AnteoTech